The 3 Best Stocks to Gift Yourself This Holiday Season

NYSE: PFE | Pfizer Inc. News, Ratings, and Charts

PFE – With the Labor Department reporting slower inflation in November and optimism about a reduced magnitude of interest rate hikes, investors are anxiously awaiting a year-end rally. Therefore, fundamentally strong stocks Pfizer (PFE), Murphy USA (MUSA), and Berry Corporation (BRY) could be solid investments now. Keep reading….

This year has been challenging for investors and businesses as they have been punished by high inflation and aggressive interest rate hikes by the Fed. However, the recently released favorable macroeconomic data could lead to a year-end “Santa Claus rally” for the market.

The consumer price index rose 0.1% from the previous month and 7.1% from a year ago in November, lower than estimates. Corporate economist with Navy Federal Credit Union, Robert Frick, believes that cooling inflation will boost the markets and take pressure off the Fed to raise interest rates at an accelerated pace.

Amid this backdrop, quality stocks Pfizer Inc. (PFE - Get Rating), Murphy USA Inc. (MUSA - Get Rating), and Berry Corporation (BRY - Get Rating) could be solid investments to benefit from their potential rally.

Pfizer Inc. (PFE - Get Rating)

PFE discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women’s health, biosimilars, sterile injectable and anti-infective medicines, and oral COVID-19 treatment.

Over the last three years, PFE’s dividend payouts have grown at a 5.5% CAGR. Its four-year average dividend yield is 3.63%, and its forward annual dividend of $1.64 per share translates to a 3.09% yield. It is expected to pay a quarterly dividend of $0.41 per share on March 3, 2023.

On December 6, 2022, PFE and Clear Creek Bio, Inc. announced a research collaboration and exclusive license agreement to advance the discovery and development of potential inhibitors of the SARS-CoV-2 papain-like protease.

PFE’s Chief Scientific Officer, Anti-Infectives, and Head of Medicine Design, Charlotte Allerton, believes in continuing to advance clinical development opportunities for PFE’s current oral therapy as well as innovating through its internal programs and strategic partnerships to try to stay ahead of the COVID-19 virus.

For the fiscal third quarter ended October 2, 2022, PFE’s total assets increased 7.6% to $195.35 billion, compared to $181.48 billion for the fiscal year ended December 31, 2021. The company’s adjusted net income increased 39.7% year-over-year to $10.17 billion. Its non-GAAP EPS came in at $1.78, representing a 40.2% increase from the prior-year quarter.

PFE’s revenue for the quarter ending December 31, 2022, is expected to increase 2.2% year-over-year to $24.36 billion, respectively. Its EPS for fiscal 2022 is expected to increase 46.5% year-over-year to $6.48. It has an impressive earnings surprise history, surpassing its consensus EPS estimates in each of the trailing four quarters. The stock has gained 11.5% over the past month to close the last trading session at $53.07.

PFE’s POWR Ratings reflect its strong fundamentals. The stock has an overall rating of A, equating to a Strong Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.

Within the Medical – Pharmaceuticals industry, it is ranked #3 out of 160 stocks. The company has an A grade for Value and a B for Growth, Sentiment, and Quality. Click here to see the additional POWR Ratings of PFE for Momentum and Stability.

Murphy USA Inc. (MUSA - Get Rating)

MUSA engages in the marketing of retail motor fuel products and convenience merchandise. The company operates retail stores under the Murphy USA, Murphy Express, and QuickChek brands.

MUSA’s four-year average dividend yield is 0.24%, and its forward annual dividend of $1.40 per share translates to a 0.50% yield. It paid a quarterly dividend of $0.35 per share on December 1, 2022.

MUSA’s total operating revenues increased 34.7% year-over-year to $6.19 billion for the third quarter ended September 30, 2022. The company’s net income increased 111.1% year-over-year to $219.50 million. Its adjusted EBITDA increased 72.7% year-over-year to $367.00 million. In addition, its EPS came in at $9.28, representing a 133.2% increase from the prior-year quarter.

MUSA’s EPS and revenue for the quarter ending December 31, 2022, are expected to increase 15.1% and 21% year-over-year to $4.88 and $5.77 billion, respectively. The company has a commendable earnings surprise history, surpassing the consensus EPS estimates in each of the trailing four quarters. The stock has gained 41.6% year-to-date to close the last trading session at $282.06.

It is no surprise that MUSA has an overall rating of B, which translates to a Buy in our proprietary rating system.

Within the Specialty Retailers industry, it is ranked #2 out of 47 stocks. The company has a B grade for Growth, Value, and Quality.

Click here to see the additional ratings of MUSA for Momentum, Stability, and Sentiment.

Berry Corporation (BRY - Get Rating)

BRY, an independent upstream energy company, develops and produces conventional oil reserves in the western United States. It operates in two segments, Development and Production and Well Servicing and Abandonment.

BRY’s four-year average dividend yield is 5.81%, and its forward annual dividend of $0.24 per share translates to a 3.07% yield. It paid a quarterly dividend of $0.06 per share on November 28, 2022.

BRY’s total revenues for the fiscal third quarter ended September 30, 2022, increased 162.5% year-over-year to $376.45 million. Its adjusted net income increased 294.5% year-over-year to $45.52 million. Its adjusted EBITDA increased 63.5% year-over-year to $96.98 million. In addition, its adjusted EPS came in at $0.55, representing a 292.9% increase from the prior-year quarter.

Analysts expect BRY’s EPS for the quarter ending December 31, 2022, to increase 152.1% year-over-year to $0.30. Its revenue for the quarter ending March 31, 2023, is expected to increase 107.1% year-over-year to $194.87 million.

It has a commendable earnings surprise history, surpassing the consensus EPS estimates in three of the trailing four quarters. The stock has gained 4.7% year-to-date to close the last trading session at $7.83.

BRY’s strong fundamentals are reflected in its POWR Ratings. It has an overall rating of A, which translates to a Strong Buy in our proprietary rating system. Within the B-rated Energy – Oil & Gas industry, it is ranked #2 out of 91 stocks. The company has an A grade for Value and Momentum and a B for Growth and Sentiment.

Click here to see the POWR Ratings of BRY for Stability and Quality.

Want More Great Investing Ideas?

3 Stocks to DOUBLE This Year


PFE shares were trading at $54.77 per share on Wednesday afternoon, up $1.70 (+3.20%). Year-to-date, PFE has declined -4.24%, versus a -13.75% rise in the benchmark S&P 500 index during the same period.


About the Author: Malaika Alphonsus


Malaika's passion for writing and interest in financial markets led her to pursue a career in investment research. With a degree in Economics and Psychology, she intends to assist investors in making informed investment decisions. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
PFEGet RatingGet RatingGet Rating
MUSAGet RatingGet RatingGet Rating
BRYGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Trump or the Fed More Important to Stock Investors?

The S&P 500 (SPY) is flirting with new highs once again. But it is not very clear what is driving these stock price gains. That is why Steve Reitmeister shares his latest views including a market outlook, trading plan and top picks to stay on the right side of the action.

3 Dividend Growth Stocks for Long-Term Wealth

Dividend-growth stocks offer steady income and long-term value. With the Fed holding rates and inflation expected to ease, now is an opportune time to invest in companies like AbbVie (ABBV), Energy Transfer (ET), and Cheniere Energy (CQP) that consistently raise payouts. Read more…

3 Sub-$10 Tech Stocks with Multibagger Potential

The tech market is booming, fueled by AI, cloud computing, and digital transformation. With next-gen software, automation, and 5G driving growth, investors have massive opportunities. For those seeking high potential without the hefty price tag, sub-$10 stocks like Yext, Inc. (YEXT), Eventbrite (EB), and inTEST Corp. (INTT) could be your next big win. Read more...

Viavi Solutions vs. Lumentum Holdings: Which Optical Tech Stock Shines Brighter?

The optical tech industry is well-positioned for growth due to technological advancements and increasing demand for seamless connectivity. So, let’s analyze optical tech stocks, Viavi Solutions (VIAV) and Lumentum Holdings (LITE), to determine which optical tech stock shines brighter. Read on...

Investors in “Wait and See” Mode

Have you noticed that the S&P 500 (SPY) has been trading in a tight trading range of only 6,000 to 6,100 the past few weeks? Steve Reitmeister shares why this is happening along with a game plan for being on the right side of the market action. Read on for the full story...

Read More Stories

More Pfizer Inc. (PFE) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All PFE News